Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology.
|Title||Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology.|
|Publication Type||Journal Article|
|Year of Publication||2005|
|Authors||McDougle, CJ, Scahill L, Aman MG, McCracken JT, Tierney E, Davies M, Arnold EL, Posey DJ, Martin A, Ghuman JK, Shah B, Chuang SZ, Swiezy NB, Gonzalez NM, Hollway J, Koenig K, McGough JJ, Ritz L, Vitiello B|
|Journal||The American journal of psychiatry|
|Date Published||2005 Jun|
|Keywords||Adolescent, Antipsychotic Agents, Autistic Disorder, Child, Communication Disorders, Conduct Disorder, Double-Blind Method, Female, Humans, Interpersonal Relations, Male, Personality Inventory, Placebos, Psychiatric Status Rating Scales, Risperidone, Stereotyped Behavior, Stereotypic Movement Disorder, Treatment Outcome|
Risperidone has been found efficacious for decreasing severe tantrums, aggression, and self-injurious behavior in children and adolescents with autistic disorder (autism). The authors report on whether risperidone improves the core symptoms of autism, social and communication impairment and repetitive and stereotyped behavior.
|Alternate Journal||Am J Psychiatry|